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INTRODUCTION
Pancreatic cancer remains one of the most lethal cancer diagnoses, having a 5-year mortality rate of less than 5%. 1) The high mortality rate of pancreatic cancer is due to the high incidence of metastatic cancer at the time of diagnosis and lack of systemic cure.
2) Unfortunately, only 5 to 25% of patients present with tumors are resectable. 1) The therapeutic options for patients include external beam irradiation with chemotherapy, intra-operative radiation therapy and EBRT (external beam radiotherapy) with novel chemotherapeutic and targeted agents. However, the delivery of lethal dose of radiation to a tumor while sparing nearby normal tissues remains a challenge in radiation therapy. In particular, tolerance of normal tissues in the upper abdomen (liver, kidney, spinal cord, and bowel) is also limited. 1) Another issue is poor local tumor control and poor results achieved using known conventional methods. In order to improve tumor control, specialized radiation therapy techniques that increase radiation dose to the tumor volume have been used without increasing normal tissue morbidity. One of these include the use of iodine-125 implants 3) or intraoperative electrons as a dose escalation technique in combination with external beam irradiation and chemotherapy.
Currently, the principal diagnostic tools are helical computed tomography (CT), endoscopic ultrasound, and laparoscopy. These modalities have facilitated the characterization of the primary tumor. The most commonly used diagnostic and staging examination is an abdominal CT scan. Newer generation CT allows high resolution, motion free images of the pancreas and its surrounding structures to be obtained at varying phases of enhancement.
Because of the high rate of mortality associated with pancreatic cancer, the quality of life should be one of the important endpoints in the study design of this disease. Novel approaches for early detection, better staging and effective treatment will make the most impact on the clinical management of this disease. We propose that gold nanoparticles be developed and designed to target pancreas cancer in order to improve the current systems used in managing such tumors.
The introduction and development of gold nanoparticles has led to studies dealing with its potential for medical imaging and diagnostic applications. Gold is considered a high atomic number material (Z = 79) and absorbs x-rays as shown in Fig. 1 .
4)
Most anti-cancer agents do not greatly differentiate between cancerous and normal cells, leading to systemic toxicity and adverse effects. 5) This greatly limits the maximum allowable dose of the drug. In addition, rapid elimination and widespread distribution into targeted organs and tissues requires the administration of the drug in large quantities, which is not economical and often results in undesirable toxicity. Comparatively, the unique features of gold nanoparticles are as follows: 6) low toxicity, low osmolality even at high concentrations, low viscosity (easy to inject even into small vessels) and it enhances radiotherapy dose, which makes it a good candidate either as a contrast agent or as a radio enhancer. Gold nanoparticles have been actively investigated in a wide variety of biomedical applications for several reasons: it has the advantage of small size which is highly tunable (1-100 nm), 7) capable of evading the immune system, 7) easy to characterize by UV-vis spectrophometry, ICP-AES or ICP-MS and TEM. 8) It has been demonstrated by Hainfeld's group that gold nanoparticles can be used as a contrast agent 9) and also as a radio-enhancer.
10) It was also evaluated numerically that gold nanoparticles can be used as a contrast agent. 11) Shirato's group demonstrated that 2 mm gold can be used as an internal fiducial marker of tumors in their real time tumor tracking radiation therapy.
12) It was reported that although implantation of the fiducial was successful, it is not without technical issues. One is the size of the fiducial itself, requiring it to be transported via large needle, which itself poses danger to blood vessel. The size of the fiducial also makes it difficult to penetrate hard tissue, such as pancreatic tumor.
2) The way to circumvent this is to use gold nanoparticles.
Our particular interest on using gold lies on its size tunability and its potential use either as radiosensitizer/dose enhancer in the treatment of cancer or as a contrast agent for diagnostic imaging of cancer using X-ray DDS (Drug Delivery System). Our group is involved in the development of pinpoint keV/MeV X-ray source for X-ray DDS. [13] [14] [15] The X-ray DDS uses advanced nano-scaled polymers which contain and deliver drug or contrast agent to cancers. Figure 2 shows the mechanism of X-ray DDS and the schematic diagram of the future pinpoint X-ray DDS, respectively. This new modality combining physical energy (via pinpoint Xray source) and drug (via DDS) in one compact system is very important for diagnosis and therapy of cancer. In the perspective of future applications of cancer treatment and/or diagnosis, advanced medical sources must be considered. 16) The in-vitro evaluation of the combination of gold nanoparticles and physical energies via X-ray DDS is necessary for the development of a safe and effective treatment and/or imaging modality. To develop successful cell-based therapies and to monitor cell trafficking in vivo, it is important to assess the fate and distribution of cells non-invasively. Biocompatibility, toxicity and the ability to penetrate the cells are three critical factors that will determine the utility of nanoparticles in clinical application. For improved uptake of gold nanoparticles, the preparations need to be optimized or modified. Particles that do not internalize and stay attached to the outer cell membrane are likely to interfere with cell surface interactions (including cell homing into tissues), may detach easily from the membrane or can be transferred to other cells. Fundamental studies on uptake of nanoparticles, investigating factors such as size, incubation time and concentration play an important role in the design of safe nanoparticles for diagnostic and therapeutic applications.
In this paper, we present the results of gold nanoparticle uptake of human pancreas cancer cell lines, taking into account factors such as gold nanoparticle size, incubation time and concentration. We aim to compare how the uptake of gold nanoparticles is affected by these factors. Eventually, by combining these parameters, the uptake of gold nanoparticles by cancer cells can be confirmed and optimized for its future application in X-ray DDS.
MATERIALS AND METHODS

Reagents and chemicals
Gold nanoparticles (5, 10, 20, 30, 40, 50 nm) were supplied from British Biocell International. Commercial gold chloride concentration was 0.01% and the mean diameter variation is less than 10%. Gold standard used is Au 1000 (Kanto Chemical Co. Inc).
Characterization of gold nanoparticles
Prior to use in cell experiments, the gold nanoparticles were initially characterized using AAS (atomic absorption spectroscopy), UV-vis spectrometry and TEM.
The gold content of the samples was determined using AAnalyst 800 atomic absorption spectrometer (PerkinElmer) with THGA graphite furnace, gold hollow-cathode lamp and AS-800 autosampler. All analyses were performed at a wavelength of 242.8 nm using 0.7 nm slit width. New graphite tubes were conditioned by heating and the machine was recalibrated prior to use. For the evaluation of peak profiles, the calculation of peak area and permanent storage peak profiles, AAWinlabTM software was used. Argon was used as the inert gas.
Initial experiments were also conducted to check for aggregation of 20 nm gold nanoparticles using different media with serum. Aggregation was monitored at several intervals between 1 to 48 h. UV-vis spectrum was measured in optical units with peak at 520 nm. 18) To confirm the diameter of gold nanoparticles used in the experiment, TEM images were obtained.
Cell culture
We used human cancer cells for these experiments. PK-1, PK-45, and Panc-1 were purchased from Riken cell bank (RIKEN, Tsukuba). PK-1, PK-45, Panc-1 are all human pancreas cancer cells.
The cell medium for the cell lines used was RPMI-1640 (GIBCO, 11875, RPMI-1640), supplemented with 10% serum (HYCLONE, SH30396.03, Fetal Bovine Serum). Cells were continuously subcultured in T-25 flask (BD Falcon, 353108) and prior to achieving confluency, cells were re-seeded into 60 mm dishes (BD Falcon, 353002, T-25) for gold nanoparticle treatment. To ensure uniform cell count during the experiment, samples were prepared per condition per cell type. Six dishes were prepared for each treatment condition: one for control, one for cell counting and the remaining for gold nanoparticle treatment. While the cells were on the exponential phase, gold nanoparticles were diluted with media (2.5 mL) to achieve the desired concentration. Dishes were stored in a humidified atmosphere at 37°C, 5% CO2 in air, except when specified. Treatment duration time depends on the condition to be tested.
After gold nanoparticle treatment, cells were washed three times with 1 mL Dulbecco Phosphate Buffered Saline (SIGMA, D8537, DPBS). The cells were collected from the dish by trysinization, using trypsin-EDTA solution (0.05% trypsin, 0.02% EDTA, T3924, SIGMA), counted (Nucleocounter) and transferred to 1.5 mL eppendorf tubes. The cell solution was homogenized using a sonicator (Tomy HandSonic).
Determination of uptake by AAS
The concentration of gold nanoparticles used was verified using AAS. Cell digestion was initially performed but results showed that homogenized and digested samples gave no significant difference in the detected gold content of the samples. In AAS analysis, a five-point calibration curve using 1000 ppm Au standard diluted to a maximum of 100 ppb was used. The gold content of the samples was determined by AAS as previously described 19) with minor modifications. Samples were diluted 1 to 50 fold by adding 0.5% HCl. Using an autosampler, 20 μL of diluted sample and 5 μL of matrix modifier (0.1% palladium and 0.06% magnesium nitrate in 1.5% HNO3) were injected into the graphite furnace to measure the gold content of the sample. Two replicates were taken for each sample analyzed.
RESULTS AND DISCUSSION
The effect of gold nanoparticle size, incubation time and concentration on the uptake of pancreas cancer cell lines used were investigated. For diagnostic and medical purposes, uptake data were presented in gold amount (nmol) per cell, and not as number of gold particles per cell. The concentration of gold detected in the sample using AAS is simply divided by the average number of cells present in the sample.
Characterization of gold nanoparticles
UV-vis spectrum of the media with serum and gold nano-particles between 1 and 48 hours was obtained. In Fig. 3 , the absorption values of 20 nm gold nanoparticles incubated in different media with serum between 1 to 48 hours are shown.
It was found that gold nanoparticles aggregate within three hours when combined with MEM, MEM-alpha, DMEM media. The absorption curves confirmed that 20 nm gold nanoparticles are stable when used with RPMI-1640 and least stable for MEM and DMEM media. The shift of the absorption curve implies aggregation. Aggregation occurred three hours after mixing, which also happens when gold nanoparticles are mixed with PBS (phosphate buffered saline).
To confirm the size of gold nanoparticles used in the experiment, TEM of gold nanoparticles of different sizes (10 nm, 20 nm, 30 nm, 40 nm, 50 nm, 100 nm) was obtained (Fig. 4) .
Size-dependence uptake
Cells were treated with 11.8 μM gold nanoparticles of various sizes mixed with media for 24 hours. In Fig. 5 , the gold content per cell versus different sizes of the nanoparticles showed that the uptake is highly dependent on size. Among the gold nanoparticles used, 5 and 10 nm gold nanoparticles have significantly lower uptake (at least 5x lower) compared to 20 nm. This trend was observed on all cells used in the experiment, with 20 nm gold nanoparticles uptake being higher compared to the 30, 40 and 50 nm gold nanoparticles. Based on these results, we will be reporting the remaining uptake dependence using 20 nm gold nanoparticles.
The mechanism of uptake is facilitated by serum adsorbed on the nanoparticles surface. This mechanism for uptake is called receptor mediated endocytosis (RME). Gold nanoparticles are hydrophobic and the protein serum in the media is adsorbed on the surface of the gold nanoparticles. The adsorption of serum proteins on the surface is very important in the internalization of gold nanoparticles by the cells. Adsorption of serum proteins is also important to prevent aggregation of gold nanoparticles, which can affect the uptake mechanism of the cell. Determining the media to be used in cell experiments where aggregation was not observed is very important to ensure that the size of the nanoparticles remains the same during the uptake process.
The protein serum-coated gold nanoparticles aid in the RME mechanism of the cell. RME is an endocytotic mechanism in which specific molecules enter the cell. Cells have a limited number of receptors on the membrane, and through these receptors the gold nanoparticles enter the cell.
The RME mechanism explains the size selectivity for different cell lines. Other factors such as ratio of adhesion and membrane stretching, the membrane's bending energy, may also affect size selectivity. Gao et al. 20) suggested that the wrapping time is dependent on particle size. Wrapping time describes how a membrane encloses a particle. For smaller particles, the receptors need to be filled-up before the nanoparticles are wrapped by the cell membrane and uptaken by the cell. If the receptors are empty, the signal for the cell to wrap around the nanoparticles is delayed, leading to longer wrapping time and hence to lower uptake. For larger nanoparticles, the uptake requires more receptors before the cell membrane can wrap itself around it, leading also to longer wrapping time, hence lower uptake. For HeLa cells, it was reported that 50 nm has the highest uptake 8) whereas from our result, pancreas cancer cell lines have optimum uptake at 20 nm (Fig. 5) . This result confirms that the gold nanoparticle uptake is cell and size dependent.
Dependence on incubation time
Cells were treated with 47.2 μM 20 nm gold nanoparticles from 1 to 48 hours. The incubation time is one of the factors that affect the accumulation of gold nanoparticles into the cell. For therapeutic and diagnostic applications, it is important that cancer cells contain sufficient gold nanoparticles for optimized treatment or imaging. In Fig. 6 , the uptake of gold nanoparticles increased gradually as the incubation time was increased. Although the incubation time was doubled at each step, the gold content of each cell did not increase proportionally. Also, a plateau in the uptake was not observed indicating that the cells can continuously uptake gold nanoparticles beyond 48 h. Previous reported results indicated that HeLa cell approaches a plateau within 4 to 7 h of incubation. 8) This indicates that incubation time varies from cell to cell.
Approaching the plateau of uptake could mean two things, one of which is that there are fewer nanoparticles in the solution (receptors are empty and wrapping of the cell membrane is delayed), second is that the cells were already saturated with gold nanoparticles that some are released back into the solution. For both cases, even if the incubation time is increased, uptake will not increase. 
Dependence on concentration
The effect of concentration on the gold nanoparticle uptake of pancreas cancer cells was also investigated as shown in Fig. 7 . Cells were treated with 11.8, 23.6, 47.2 and 94.4 μM of 20 nm gold nanoparticles for 24 hours. From  Fig. 7 , the uptake of gold nanoparticles increased as the concentration was increased. For the concentrations considered in this experiment, plateau was not observed (Fig. 7) . The fewer gold nanoparticles are in the solution, the lesser chance for a receptor to receive gold nanoparticle; membrane wrapping time is longer, resulting to lower uptake by the cell. Also, at lower concentrations, increasing the incubation time will not increase the gold nanoparticle uptake of the cell because of fewer nanoparticles reaching the receptors. However, for the case when there are abundant gold nanoparticles present in the solution, receptors will be able to receive nanoparticles faster and easier, leading to shorter wrapping times and higher uptake by the cell. Hence, higher uptake of gold nanoparticles into cells can be achieved by using the appropriate nanoparticles size in combination with optimum incubation time and concentration.
Temperature-dependence uptake
The effect of temperature on the uptake of gold nanoparticles was investigated. PK-1, PK-45H and Panc-1 were incubated for 24 hours with 11.8 μM of 20 nm gold nanoparticles at 37°C, 39°C, 41°C. The results are shown in Fig.  8 . For PK-1, PK-45H and Panc-1, the uptake was not significantly affected by temperature.
We aim to develop gold nanoparticles for non-invasive imaging for future dynamic tracking radiation therapy and X-ray DDS. To achieve this, the intracellular uptake of gold nanoparticles was investigated using human pancreas cancer cells PK-1, PK-45H and Panc-1. Intracellular uptake using different gold nanoparticle sizes was measured using AAS. It was found that the uptake of 20 nm gold nanoparticles was higher compared to other gold nanoparticle sizes. The dependence on incubation time and concentration was also investigated. Accumulation of gold nanoparticles can be increased further through longer incubation and higher concentration. From our present results, we were able determine optimum conditions for the uptake of gold nanoparticles by pancreas cancer cells.
The findings of this study will help in the design and optimization of the nanoparticle uptake for therapeutic and diagnostic applications of X-ray Drug Delivery System. At this point, in-vitro and in-vivo experiments are necessary to determine specific amounts that cancer cells need to uptake for imaging and therapeutic applications. In-vivo experiments are also underway to determine distribution of gold nanoparticles to different tissues and organs. Further investigations will be also conducted combining gold nanoparticles and polymers in in-vitro and in-vivo in order to develop X-ray DDS for verification of safe and effective use of gold nanoparticle-based agents in the near future. 
